Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours Β· Estimated delivery Aug 30 - Sep 4
The environment is very peaceful
Eligibility requirements for the GLP-1 Bridge Program include: Age 18 or older Enrollment in a Medicare Part D or Medicare Advantage Prescription Drug (MA-PD) plan One of the following BMI and health condition combinations: BMI 35 (regardless of other health conditions) BMI 30 with at least one of the following: heart failure with preserved ejection fraction (HFpEF), hypertension, or chronic kidney disease (CKD) BMI 27 with a history of pre-diabetes, myocardial infarction, stroke, or peripheral artery disease (PAD) The program covers the following GLP-1 receptor agonists: Foundayo (orforglipron) tablet, all dose strengths and formulations Wegovy (semaglutide) injections and tablets, all dose strengths and formulations Zepbound (tirzepatide) injections, only when prescribed as the KwikPen (single-dose vials and other single-dose pen formats are excluded) All prescriptions require prior authorization through Humana, which oversees clinical review to ensure adherence to the program's strict medical-necessity guidelines
A dietitian can help you choose nutrient-rich foods you enjoy, plan meals that fit your smaller appetite, and suggest ways to manage side effects (like which foods to eat when feeling nauseous)
DPP4-deficient congenic rats display blunted stress, improved fear extinction and increased central NPY
These drugs are administered via injectables, with some oral variants in development
US$ 22.76
US$ 25.86
US$ 20.38
US$ 22.30
US$ 24.16
